Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rockwell Medical In (RMTI) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 282,370
  • Shares Outstanding, K 51,530
  • Annual Sales, $ 55,350 K
  • Annual Income, $ -14,420 K
  • 36-Month Beta 2.07
  • Price/Sales 5.23
  • Price/Book 5.06

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.06 +4.15%
on 01/23/17
6.80 -22.50%
on 01/05/17
-1.17 (-18.17%)
since 12/23/16
3-Month
3.55 +48.45%
on 11/08/16
8.37 -37.04%
on 12/09/16
-0.82 (-13.46%)
since 10/21/16
52-Week
3.55 +48.45%
on 11/08/16
10.58 -50.19%
on 06/03/16
-2.14 (-28.88%)
since 01/22/16

Most Recent Stories

More News
Implied Volatility Surging for Rockwell Medical (RMTI) Stock Options

Investors in Rockwell Medical, Inc. (RMTI) need to pay close attention to the stock based on moves in the options market lately

Blog Coverage Pfizer Fined $107 Million for Overcharging Through an Antiepileptic Drug

Upcoming AWS Coverage on Rockwell Medical Post-Earnings Results

Notable Thursday Option Activity: RMTI, SAFM, VLO

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rockwell Medical, Inc , where a total of 3,211 contracts have traded so far, representing approximately...

Downtrend Call Working As Rockwell Medical Technologies Stock Falls 30.1% (RMTI)

SmarTrend identified a Downtrend for Rockwell Medical Technologies (NASDAQ:RMTI) on June 22nd, 2016 at $7.44. In approximately 5 months, Rockwell Medical Technologies has returned 30.06% as of today's...

Downgrade Alert for Rockwell Medical Technologies (RMTI)

Rockwell Medical Technologies (NASDAQ:RMTI) was downgraded from Neutral to Underperform at BofA/Merrill today. The stock closed yesterday at $4.51 on volume of 3.5 million shares, above average daily...

Rockwell Medical Reports Third Quarter Results

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the...

Rockwell Medical Schedules Third Quarter 2016 Earnings Call

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

Rockwell Medical Technologies Down 21.9% Since SmarTrend Downtrend Call (RMTI)

SmarTrend identified a Downtrend for Rockwell Medical Technologies (NASDAQ:RMTI) on June 22nd, 2016 at $7.44. In approximately 4 months, Rockwell Medical Technologies has returned 21.86% as of today's...

18.8% Return Seen to Date on SmarTrend Rockwell Medical Technologies Call (RMTI)

SmarTrend identified a Downtrend for Rockwell Medical Technologies (NASDAQ:RMTI) on June 22nd, 2016 at $7.44. In approximately 4 months, Rockwell Medical Technologies has returned 18.76% as of today's...

Rockwell Medical to Present Data on Peritoneal Dialysis (PD) Administration of Triferic at American Society of Nephrology (ASN) Meeting November 2016

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Support & Resistance

2nd Resistance Point 5.69
1st Resistance Point 5.48
Last Price 5.27
1st Support Level 5.06
2nd Support Level 4.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.